在线日韩日本国产亚洲丨少妇伦子伦情品无吗丨欧美性猛交xxxx免费看蜜桃丨精品人妻系列无码一区二区三区丨亚洲精品无码不卡在线播放

Your Good Partner in Biology Research

Phospho-MYOD1 (Ser200) Antibody

  • 中文名稱:
    磷酸化-MYOD1 (Ser200)兔多克隆抗體
  • 貨號:
    CSB-PA165049
  • 規格:
    ¥2454
  • 圖片:
    • Western blot analysis of extracts from Hela cells untreated or treated with EGF using MyoD(Phospho-Ser200) Antibody.
  • 其他:

產品詳情

  • 產品名稱:
    Rabbit anti-Homo sapiens (Human) MYOD1 Polyclonal antibody
  • Uniprot No.:
  • 基因名:
    MYOD1
  • 宿主:
    Rabbit
  • 反應種屬:
    Human,Mouse,Rat
  • 免疫原:
    Peptide sequence around phosphorylation site of serine 200 (A-S-S(p)-P-R) derived from Human MyoD.
  • 免疫原種屬:
    Homo sapiens (Human)
  • 克隆類型:
    Polyclonal
  • 純化方式:
    Antibodies were produced by immunizing rabbits with synthetic phosphopeptide and KLH conjugates. Antibodies were purified by affinity-chromatography using epitope-specific phosphopeptide. Non-phospho specific antibodies were removed by chromatogramphy usi
  • 濃度:
    It differs from different batches. Please contact us to confirm it.
  • 產品提供形式:
    Liquid
  • 應用范圍:
    ELISA,WB
  • 推薦稀釋比:
    Application Recommended Dilution
    WB 1:500-1:1000
  • Protocols:
  • 儲存條件:
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • 貨期:
    Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
  • 用途:
    For Research Use Only. Not for use in diagnostic or therapeutic procedures.

產品評價

靶點詳情

  • 功能:
    Acts as a transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation. Together with MYF5 and MYOG, co-occupies muscle-specific gene promoter core region during myogenesis. Induces fibroblasts to differentiate into myoblasts. Interacts with and is inhibited by the twist protein. This interaction probably involves the basic domains of both proteins.
  • 基因功能參考文獻:
    1. We address this paradox using basic helix-loop-helix (bHLH) transcription factors ASCL1, ASCL2, and MYOD1, crucial mediators of lineage specification..Although the ASCL factors and MYOD1 have some distinct DNA motif preference, it is not sufficient to explain the extent of the differential binding. All three factors can bind inaccessible chromatin and induce changes in chromatin accessibility and H3K27ac PMID: 29500235
    2. ACL regulates the net amount of acetyl groups available, leading to alterations in acetylation of H3(K9/14) and H3(K27) at the MYOD locus, thus increasing MYOD expression. PMID: 29241530
    3. we found that MYOD transcription factor can upregulate miR-223 expression by binding to an E-box region of the gga-miR-223 gene promoter during avian myoblast differentiation. IGF2 and ZEB1 are two target genes of miR-223 PMID: 28981085
    4. A high extent more than 25% of BRAF(V600E) alleles may be associated with disease outcome in PTC patients. PMID: 27688110
    5. we present the first report of MYOD1 (L122R) mutation in the largest cohort of 49 rhabdomyosarcomas reported so far, that are associated with a relatively aggressive clinical course PMID: 27562493
    6. Cell transdifferentiation of primary skin fibroblasts by forced expression of myogenic transcription factor MyoD was performed by quantitative analyses of gene expression and chromatin accessibility profiles. PMID: 28977539
    7. Analysis of the chromatin status of Cdkn1c promoter and KvDMR1 in unresponsive compared to responsive cell types showed that their differential responsiveness to the MyoD-dependent induction of the gene does not involve just their methylation status but, rather, the differential H3 lysine 9 dimethylation at KvDMR1. PMID: 27611768
    8. Data show that MeCP2 promotes gastric cancer (GC) cell proliferation via FOXF1-mediated Wnt5a/beta-Catenin signaling pathway, and suppresses GC cell apoptosis through MYOD1-mediated Caspase-3 signaling pathway. PMID: 28131747
    9. Our results on Pax7 and MyoD protein expression suggest that proliferation and differentiation of skeletal muscle stem cells are affected in ALS patients, and the myogenic processes cannot overcome the denervation-induced wasting. PMID: 27195289
    10. The molecular pathogenesis of radiotherapy-induced muscle fibrosis involves the TGF-beta1 pathway and its repression of MyoD expression. Our results suggest a correlation between traditional swallow therapy /neuromuscular electrical stimulation combined therapy and the restoration of TGF-beta1/MyoD homeostasis in cervical muscles. PMID: 27144672
    11. Unmethylated MYOD1 gene is associated with chemoradiation resistance in Invasive Cervical Carcinoma. PMID: 26344356
    12. We provide the first description of a human phenotype that appears to result from MYOD1 mutation. The presentation with Lethal fetal akinesia deformation sequence is consistent with a large body of data demonstrating that in the mouse, MyoD is a major controller of precursor cell commitment to the myogenic differentiation programme PMID: 26733463
    13. these results suggest that sarcoma metastasis can be partially controlled through Pax7/MyoD-dependent activation of miR-182 and provide insight into the role that myogenic transcription factors have in sarcoma progression PMID: 26234681
    14. The mechanism of bakuchiol-induced myogenesis is described. PMID: 26902638
    15. These observations demonstrated the first time that Wnt3a can directly activate MyoD expression through targeting cis-elements in the DE and the L fragment. PMID: 25651906
    16. Studies indicate that MyoD occupies multiple promoters that induce the transcription of genes vital for establishing the myogenic fate and is also implicated as a mediator of many chromatin modifying enzymes for their recruitment to myogenic enhancers. PMID: 24905980
    17. MUNC is not a classic cis-acting enhancer RNA (e-RNA) acting exclusively by stimulating the neighboring MyoD gene PMID: 25403490
    18. MyoD acts to promote SC proliferation and transition of cells into differentiation, while myogenin is known to drive terminal differentiation PMID: 25108351
    19. A recurring point mutation in MYOD1 is found in 10% of embryonal rhabdomyosarcomas with distinct clinical features and poor prognosis. PMID: 25002625
    20. Spindle cell and sclerosing rhabdomyosarcoma show recurrent MYOD1 mutations, in keeping with a single pathologic entity, regardless of age at presentation. PMID: 24824843
    21. MyoD was required for the induction of FGF21 gene transcription by mitochondrial dysfunction. PMID: 25055037
    22. analysis of a mutation in MYOD1 that may have a role in progression of embryonal rhabdomyosarcoma and may be associated with mutations altering PI3K-AKT pathway components PMID: 24793135
    23. MYOD1 homozygous mutations are frequent, recurrent and pathognomonic events in adult-type spindle cell Rhabdomyosarcoma PMID: 24272621
    24. Although expression of MyoD in a proliferating tumor is insufficient to prevent tumor progression, its expression in the cerebellum hinders medulloblastoma genesis. PMID: 24092238
    25. Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein. PMID: 23438194
    26. MYOD1-transduced amnion-derived cells are capable of the dystrophin expression necessary for myogenic differentiation. PMID: 22727434
    27. CRABP2 promotes myoblast differentiation and is modulated by the transcription factors MyoD and Sp1 in C2C12 cells. PMID: 23383201
    28. SREBP-1 regulate muscle protein synthesis through the downregulation of the expression of MYOD1, MYOG and MEF2C factors. PMID: 23226416
    29. Using both primary human muscle cells and RD rhabdomyosarcoma cells, the study shows that MyoD binds in a similar genome-wide pattern in both tumor and normal cells but binds poorly at a subset of myogenic genes that fail to activate in the tumor cells. PMID: 23230269
    30. Promoter gene hypermethylation of the MYOD-1 gene increases significantly with age in normal individuals and thus may offer potential as a putative biomarker for colorectal cancer. PMID: 22591756
    31. Human squamous cell carcinomas and malignant melanomas contain significantly more Myo/Nog cells than basal cell carcinomas. PMID: 22621191
    32. results suggest that MyoD and TIP120B potentiate each other at gene expression and post-translation levels, respectively, which may promote myogenesis cooperatively PMID: 22613845
    33. the involvement of HUWE1 in the ubiquitination and proteasomal degradation of MyoD was described. PMID: 22277673
    34. BAF60c-MyoD complex directs recruitment of SWI/SNF to muscle loci in response to differentiation cues. PMID: 22068056
    35. Data demonstrate radical acceleration of iPSC creation with a fusion gene between Oct4 and the powerful transactivation domain (TAD) of MyoD. PMID: 21732495
    36. Using MYOD1, study shows that an nucleosome-depleted region at the minimal enhancer region allows reprogramming to be initiated, which occurs in response to signals such as the forced expression of Myod1 in fibroblasts. PMID: 22153073
    37. The myofibroblasts demonstrate the capacity for de-differentiation and proliferation by modulation of endogenous levels of MyoD. PMID: 21440539
    38. MyoD can play an active role in Alveolar rhabdomyosarcoma (ARMS)by augmenting Pax7-FKHR function. PMID: 21321994
    39. Increases in MYOD indicate that 1 week of conventional resistance exercise may increase myogenic activity, including satellite cell proliferation and differentiation, respectively, in younger men. PMID: 21326383
    40. Mef2d, Six4, and p38alpha MAPK function coordinately as regulators of a master regulator to mediate expression of MyoD target genes. PMID: 20716948
    41. Knockdown of MyoD and PEA3 attenuated MDR1 expression and increased the sensitivity of multidrug resistant cancer cells to cytotoxic drugs that were transported by P-gp in SGC7901/VCR cells. PMID: 20980337
    42. Transgenic Pax7 and MyoD are not essential for myogenic differentiation and participation of bone marrow-derived myogenic progenitors in muscle regeneration. PMID: 20333749
    43. calpain 3 participates in the establishment of the pool of reserve cells by decreasing the transcriptional activity of the key myogenic regulator MyoD via proteolysis independently of the ubiquitin-proteasome degradation pathway. PMID: 20139084
    44. MYOD1 hypermethylation plays an important role in colorectal cancer and may be a novel prognostic factor. PMID: 14767572
    45. MyoD modulates the rate of Id1 degradation and suggest a dynamic interplay of these factors PMID: 15163661
    46. Hypermethylation of MYOD1 is statistically significantly associated with poor disease outcome in cervical cancer. PMID: 15251938
    47. degradation is modulated by E12 and E47 PMID: 16007194
    48. This review highlights studies of molecular mechanisms by which the muscle-specific myogenic basic helix-loop-helix protein MyoD interacts with other regulatory factors to coordinate gene expression in a controlled and ordered manner. PMID: 16099183
    49. The expression of MyoD1 was more sensitive but less specific in patients with rhabdomyosarcoma. PMID: 16435141
    50. The results establish that cdk9/cyclin T2a-mediated coactivation of MyoD depends on serine 37 phosphorylation. PMID: 16841087

    顯示更多

    收起更多

  • 亞細胞定位:
    Nucleus.
  • 數據庫鏈接:

    HGNC: 7611

    OMIM: 159970

    KEGG: hsa:4654

    STRING: 9606.ENSP00000250003

    UniGene: Hs.181768



主站蜘蛛池模板: 成人国产一区二区三区精品| 无码任你躁久久久久久老妇| 熟妇熟女乱妇乱女网站| 中文字幕久久久久人妻中出| 国产美熟女乱又伦av果冻传媒 | 成熟丰满熟妇高潮xxxxx| 免费国产黄网站在线观看动图| 香蕉伊蕉伊中文视频在线| 亚洲高潮喷水无码av电影| 亚洲欧美国产制服图片区| 久久午夜伦鲁片免费无码| 日本夜爽爽一区二区三区| 精品视频一区二区三区在线观看| 2021久久精品国产99国产精品| 欧美性猛少妇xxxxx免费| 永久免费无码网站在线观看| 中文在线а天堂中文在线新版| 大陆精大陆国产国语精品| 久久中文字幕无码中文字幕有码| 日韩国产亚洲高清在线久草| 日本熟人妻中文字幕在线| 午夜dv内射一区区| 自拍偷在线精品自拍偷99| 欧美日韩人妻精品一区二区在线| 欧美在线精彩视频免费播放| 两个人看的www视频免费完整版| 特级无码毛片免费视频播放▽| 亚洲日本中文字幕乱码在线 | 青青草国产精品人人爱| 8888四色奇米在线观看| 脱岳裙子从后面挺进去在线观看| 亚洲精品国产综合麻豆久久99| 欲女熟妇国产一区二区| 亚洲精品久久| 国产乱码人妻一区二区三区四区| 中文字幕精品av一区二区五区| 午夜影视免费x看| 男女一边摸一边做爽爽| 开心五月综合亚洲| 无码人妻一区二区三区免费n鬼逝| 成在线人视频免费视频|